Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 15 of 15 publications.

Doma R, Suminski N, Gold A. Landscape analysis of Alzheimer's disease-specific caregiver outcome assessments. Poster presented at the ISPOR Europe 2023; November 12, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S227. doi: 10.1016/j.jval.2023.09.1173

Gold A, Brouwer E, Hakkarainen KM, Brown D. A review of patient-reported outcomes and external control arms in regulatory submissions of novel oncology drugs. Poster presented at the ISPOR Europe 2023; November 12, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S216-7. doi: 10.1016/j.jval.2023.09.1120

Gold A, Suminksi N, Abbetz-Web L, Rudell K. Patient-focused evaluation of infant and toddler developmental clinical outcomes assessments (COAs) in clinical trials. Poster presented at the 30th Annual Conference of the International Society for Quality of Life Research (ISOQOL); October 18, 2023. [abstract] Qual Life Res. 2023 Nov 4; 32(Suppl 2):S110-1. doi: 10.1007/s11136-023-03530-x

Grant S, Gold A, Pavisic I, Doma R, Rudell K. Using qualitative methods to develop grounded relevant content for preference surveys in a Specific Rare Bleeding Disorder (SRBD). Poster presented at the ISPOR 2023; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 Supplement):S327. doi: 10.1016/j.jval.2023.03.1864

Doma R, Gold A, Gregg M, Brouwer ES, Rudell K. A secondary analysis of the cross-cultural validation of multi-dimensional postpartum health PROMs, and suggestions for improving their validity and administration. Poster presented at the ISPOR 2023; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 Supplement):S189. doi: 10.1016/j.jval.2023.03.1021

Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, Mayeda ER, Filshtein TJ, Power MC, Elahi FM, Brickman AM, Glymour MM. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis. BMJ. 2021 Feb 25;372:n156. doi: 10.1136/bmj.n156

Gold AL, Meza E, Ackley SF, Mungas DM, Whitmer RA, Mayeda ER, Miles S, Eng CW, Gilsanz P, Glymour MM. Are adverse childhood experiences associated with late-life cognitive performance across racial/ethnic groups: results from the Kaiser healthy aging and diverse life experiences study baseline. BMJ Open. 2021 Feb 5;11(2):e042125. doi: 10.1136/bmjopen-2020-042125

Gold A, Meza E, Ackley SF, Mungas DM, Whitmer R, Mayeda ER, Miles S, Eng C, Gilsanz P, Glymour MM. Adverse childhood experiences and late life cognitive performance across racial/ethnic groups: results from the KHANDLE cohort. Poster presented at the 2020 Society for Epidemiological Research 53rd Annual Virtual Meeting; December 16, 2020.

Gold A, Murchland A, Brenowitz W, Glymour MM. Estimating the effects of education of late-life cognition: a meta-analysis of instrumental variables studies based on compulsory schooling laws. Poster presented at the Society for Epidemiological Research 52nd Annual Meeting; June 18, 2019. Minneapolis, MN.

Kyu HH, Stein CE, Boschi Pinto C, Rakovac I, Weber MW, Dannemann Purnat T, Amuah JE, Glenn SD, Cercy K, Biryukov S, Gold AL, Chew A, Mooney MD, O'Rourke KF, Sligar A, Murray CJL, Mokdad AH, Naghavi M. Causes of death among children aged 5-14 years in the WHO European region: a systematic analysis for the global burden of disease study 2016. Lancet Child Adolesc Health. 2018 May;2(5):321-37. doi: 10.1016/S2352-4642(18)30095-6

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, Gold A. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017 Sep 16;390(10100):P1211-59. doi: 10.1016/S0140-6736(17)32154-2

GBD 2016 Causes of Death Collaborators, Gold A. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-210. doi: 10.1016/S0140-6736(17)32152-9

GBD 2015 Obesity Collaborators, Gold A. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362

Global Burden of Disease Child and Adolescent HealthCollaboration, Gold AL. Child and adolescent health From 1990 to 2015: findings from the global burden of diseases, injuries, and risk factors 2015 study. JAMA Pediatr. 2017 Jun 1;171(6):573-92. doi: 10.1001/jamapediatrics.2017.0250

GBD 2015 Tobacco Collaborators, Gold A. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the global burden of disease study 2015. Lancet. 2017 May 13;389(10082):1885-906. doi: 10.1016/S0140-6736(17)30819-X